front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |review |
其他推荐篇章:
1. Steinberg SM et alii.
Prognostic indicators of colon tumors: the Gastrointestinal Tumor
Study
Group Experience. Cancer 57(9):
1886-70, 1986.2. Bruinvels DJ et alii: Follow up of patients with
colorectal cancer: a meta-analysis. Annals of Surgery 219(2):
174-82, 1994.3. Filela X et alii: Prognostic value of CA 19.9 levels
in colorectal cancer. Annals of Surgery 216(1):55-9, 1992.4.
Fitzgerald SD et alii: Advanced colorectal neoplasia in the
high-risk elderly patient: is surgical resection justified ?
Diseases of the Colon and Rectum 36(2): 161-6, 1993.5. American
Society of Clinical Oncology: clinical practice guidelines for the
use of tumor markers in breast and colorectal cancer. Journal of
Clinical Oncology 14(10):2843-77, 1996.6. Mandel JS et alii:
Reducing mortality from colorretal cancer by screening for fecal
occult blood - the Minnesota Colon Cancer Control Study. N Engl J
Med May 13;328(19):1365-71, 1993.7. Kronborg O et alii: Randomised
study of screening for colorretal cancer with
faecal-occult-blood-test. Lancet Nov 30;348(9040):1467-71, 1996.8.
Hardcastle JD et alii: Randomised controlled trial of
faecal-occult-blood screening for colorretal cancer. Lancet Nov
30;348(9040):1472-7, 1996.9. Mandel JS et alii: Colorectal cancer
mortality: effectiveness of biennal screening for fecal occult
blood. J Natl Cancer Inst Mar 3;91(5):434-7, 1999.
|